Admission Date:  [**2191-3-15**]              Discharge Date:   [**2191-3-18**]  Date of Birth:  [**2132-6-22**]             Sex:   F  Service: MEDICINE  Allergies: Dilaudid  Attending:[**First Name3 (LF) 338**] Chief Complaint: respiratory distress  Major Surgical or Invasive Procedure: Vocal cord injection Intubation Bronchoscopy Arterial Line Central veinous line  History of Present Illness: 58 year old woman with stage IV SCLC with large right hilar mass, pleural effusion (had recent talc pleurodesis), right cervical [**Doctor First Name **] who had received 8 cycles of carboplatin, now on irinotecan.
Her symptoms were so severe that she had poor oral intake and was coming in for IV fluids.
After the procedure yesterday, she had improvement in her voice and decreased odynophagia.
No headache, visual changes, arthralgias, skin changes.
She was given albuterol nebs x 4 with resultant pOx 85 % on RA.
aspiration in left lower   Past Medical History: - Small cell lung cancer s/p chemo and XRT - Chronic kidney disease (baseline creatinine 2.0) presumed due to diabetes and/or hypertension - Hypertension - Hyperlipidemia - PCOS - Neuropathy in the toes secondary to diabetes - GERD - Diabetes type II .
PAST ONCOLOGIC HISTORY: - Presented [**2-/2189**] with cough, thought to be due to Lisinopril - [**7-/2189**]: developed lymphadenopathy in the right supraclavicular area which was non-mobile.
- [**2189-8-12**]: CT Chest showed large right hilar/mediastinal mass with encasement of R mainstem bronchus - [**2189-8-13**]: bronchoscopy and EUS done with biopsy confirmed small cell lung cancer; brain MRI negative - [**-8/3148**]: [**Doctor Last Name **] (6 AUC) and etoposide 60mg/m2 started as an inpatient with concurrent XRT; completed 20 session from [**Date range (3) 23906**] - chemotherapy course complicated by febrile neutropenia after cycles 1 and 2.
- [**2190-5-19**]: Disease recurrence intrathoracic and right supraclavicular lymph nodes - [**2190-6-1**] Restarted [**Doctor Last Name **]/Etoposide at doses of [**Doctor Last Name **] 5 AUC, Etoposide 60mg/m2 and Neulasta, received 6 cycles with disease response on CT - [**2190-10-12**]: Cycle 7 [**Doctor Last Name **]/Etoposide - [**2190-11-9**]: Cycle 8 [**Doctor Last Name **]/Etoposide - [**2190-11-26**]: CT Chest with stable lymphadenopathy; moderate pleural effusion   Social History: Lives with husband and pet cats in [**Name (NI) **].
CXR [**2191-3-17**] As compared to the previous radiograph, the patient has received a new left internal jugular vein catheter.
The patient also has received an endotracheal tube.
She had worsening tachypnea and was initially transferred to the hospitalist service prior to transfer to the MICU for hypotension and respiratory distress.
She died on [**2191-2-15**] at 11:13am, with causes including pneumonia, STEMI and SCLC.
She was intubated for respiratory support and started on vancomycin, cefepime, zosyn, micafungin, and voriconazole.
She required increasing ventilation requirements throughout the hospital stay.
She required increasing pressors but her bicarb and urine continued to decline.
On [**2-15**], after a discussion with the family, it was decided that further escalation of care and/or CPR would be futile.
Treated likely pneumonia with vancomycin, cefepime, micafungin, voriconazole and zosyn.
Medications on Admission: - Lantus 4-6 units qAM and 6 units qHS - Humalog 4 units qAM and 4-6 units at suppertime - Ativan 0.5 mg PO qD - omeprazole 40 mg PO qD - setraline 100 mg PO BID - benzonatate 100 mg PO TID - guaifenesin 400 mg PO q 6 hr prn cough - prochlorperazine 10 mg PO q 6 hr prn - ondansetron 8 mg PO BID prn - Imodium 2 mg PO prn   Discharge Medications: N/A  Discharge Disposition: Expired  Discharge Diagnosis: Pneumonia ST Elevation Myocardial Infarction Small cell lung cancer  Discharge Condition: Deceased  Discharge Instructions: N/A  Followup Instructions: N/A
